SEC CIK 1405279
Ahlholm Frederick W
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| NERVview stock → | 17,518 | 2023-05-01 |
| AMRNview stock → | 0 | 2011-04-20 |
Position History — NERV
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — NERV
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-06-03 | Grant / award (derivative) | 680,000 | $0.00 | 680,000 |
| 2025-12-22 | Grant / award (derivative) | 500,000 | $0.00 | 500,000 |
| 2024-12-05 | Grant / award (derivative) | 47,500 | $0.00 | 47,500 |
| 2023-10-04 | Grant / award (derivative) | 42,850 | $0.00 | 42,850 |
| 2023-05-01 | Open-market sale | 3,580 | $4.48 | 17,518 |
| 2023-04-28 | Grant / award | 19,843 | $0.00 | 21,098 |
| 2022-12-13 | Grant / award (derivative) | 26,000 | $0.00 | 26,000 |
| 2022-02-16 | Grant / award (derivative) | 180,000 | $0.00 | 180,000 |
| 2020-12-16 | Open-market sale | 1,845 | $2.64 | 10,039 |
| 2020-12-14 | Option exercise (derivative) | 5,000 | $0.00 | 0 |
| 2020-12-14 | Option exercise | 5,000 | — | 11,884 |
| 2020-10-13 | Grant / award (derivative) | 85,000 | $0.00 | 85,000 |
| 2020-06-19 | Grant / award (derivative) | 137,784 | $0.00 | 137,784 |
| 2020-05-26 | Open-market sale | 8,339 | $15.00 | 6,884 |
| 2019-12-31 | Grant / award (derivative) | 37,216 | $0.00 | 37,216 |
| 2019-12-17 | Open-market sale | 1,557 | $7.10 | 15,223 |
| 2019-12-14 | Option exercise (derivative) | 5,000 | $0.00 | 5,000 |
| 2019-12-14 | Option exercise | 5,000 | — | 16,780 |
| 2018-12-17 | Open-market sale | 1,559 | $7.46 | 11,780 |
| 2018-12-14 | Option exercise (derivative) | 5,000 | $0.00 | 10,000 |
| 2018-12-14 | Option exercise | 5,000 | — | 13,339 |
| 2018-12-11 | Grant / award (derivative) | 120,000 | $0.00 | 120,000 |
| 2017-12-14 | Option exercise (derivative) | 5,000 | $0.00 | 15,000 |
| 2017-12-14 | Option exercise | 5,000 | — | 10,000 |
| 2017-12-14 | Open-market sale | 1,661 | $5.80 | 8,339 |
| 2017-12-13 | Grant / award (derivative) | 120,000 | $0.00 | 120,000 |
| 2017-06-01 | Option exercise (derivative) | 7,250 | $0.00 | 49,750 |
| 2017-06-01 | Option exercise (derivative) | 14,381 | $0.00 | 43,143 |
| 2017-06-01 | Option exercise | 7,250 | $4.71 | 26,631 |
| 2017-06-01 | Open-market sale | 10,381 | $11.00 | 5,000 |
| 2017-06-01 | Option exercise | 14,381 | $5.19 | 19,381 |
| 2017-06-01 | Open-market sale | 11,250 | $10.00 | 15,381 |
| 2016-12-27 | Option exercise (derivative) | 12,000 | $0.00 | 57,000 |
| 2016-12-27 | Option exercise | 12,000 | $4.71 | 22,000 |
| 2016-12-27 | Open-market sale | 17,000 | $12.51 | 5,000 |
| 2016-12-14 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2016-12-14 | Grant / award (derivative) | 35,000 | $0.00 | 35,000 |
| 2015-12-04 | Grant / award (derivative) | 69,000 | $0.00 | 69,000 |
| 2015-04-14 | Grant / award (derivative) | 57,524 | $0.00 | 57,524 |
| 2014-07-01 | Open-market buy | 10,000 | $6.00 | 10,000 |
| 2014-06-30 | Grant / award (derivative) | 93,541 | $0.00 | 93,541 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.